LD-2 disclosure · 1st Quarter - Report
ABBVIE, INC.
Client
- Name
- ABBVIE, INC.
- Description
- Biopharmaceutical company
- Location
- District of Columbia · United States of America
Registrant
- Description
- Lobbying Law Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
4 issuesHealth Issues
340B Reform, FDA drug approvals, monitoring Food is Medicine initiatives, importation of biopharmaceutical products, pharmaceutical supply chain. Prescription drug advertising issues.
LobbyistsSUSAN HIRSCHMANN · CHRISTOPHER E. WILCOX · DANIEL ZIEGLER · JEANNE HAGGERTY · ROBERT BUTORA
Covered position (CHRISTOPHER E. WILCOX): LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings
Covered position (DANIEL ZIEGLER): Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn, Policy Director; Speaker Mike Johnson
Covered position (JEANNE HAGGERTY): Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member
Covered position (ROBERT BUTORA): Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Drug pricing policies, implementation of IRA drug pricing policies, access and coverage, most-favored nation drug pricing policies, ORPHAN Cures Act implementation.
LobbyistsSUSAN HIRSCHMANN · CHRISTOPHER E. WILCOX · DANIEL ZIEGLER · JEANNE HAGGERTY · ROBERT BUTORA